Clinical trials for Amyloidosis investigate a range of treatment strategies and patient populations.

15 total trials for this combination

Showing top 10 of 15 trials

Trials

NCT ID	Title	Status	Phase
NCT02909036	Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.	ACTIVE_NOT_RECRUITING	PHASE1
NCT03860935	Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy	COMPLETED	PHASE3
NCT02175004	Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)	COMPLETED	PHASE3
NCT02510261	The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)	COMPLETED	PHASE3
NCT06563895	Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	RECRUITING	PHASE3
NCT04942067	APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma	UNKNOWN	PHASE1/PHASE2
NCT07081646	A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.	RECRUITING	PHASE1/PHASE2
NCT01737398	Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy	COMPLETED	PHASE2/PHASE3
NCT05250973	A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis	ACTIVE_NOT_RECRUITING	PHASE2
NCT03201965	A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis	COMPLETED	PHASE3

Related Pages

All Amyloidosis trials All trials in New York, United States